Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATOM
2024-517128-21-02Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in migraine comparing Voltfast arm with Vydura arm (2 arms). Primary endpoint: Pain-free at 2 hours. Started May 2022; status: completed.
02
Drugs
diclofenacrimegepant
03
Conditions
migraine
Beyond the preview
Go deeper on 2024-517128-21-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517128-21-02.